Response to: Skin reactions to mRNA-1273 SARS-CoV-2 vaccine

We thank Wanget al. for their letter regarding our article on erythema multiforme after SARS-CoV-2 messenger RNA vaccination.1 We agree with Wanget al.2 that it is important to distinguish between immediate-type and delayed-type skin reactions when assessing the safety of further doses of the vaccine.
Source: QJM - Category: Internal Medicine Source Type: research